NCR Voyix Corp
Datakwaliteit: 100%
NCRRP
NYSE
Manufacturing
Industrial Machinery & Computers
€ 1.002,00
€ 0,00
(0,00%)
Marktkapitalisatie: 121,64 B
6 months return
—
Momentum
Neutral
5Y revenue growth
-21,72%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -21,72% annually over 5 years
Earnings declined -93,53% over the past year
Negative free cash flow of -210,00 M
P/E of 1961,98 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 16,80%
ROIC of 0,71% — low return on invested capital
Price History
Groei
Revenue Growth (5Y)
-21,72%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-4,92%
Earnings (1Y)-93,53%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
7,23%
Boven sectorgemiddelde (-54,47%)
ROIC0,71%
Net Margin2,31%
Op. Margin0,97%
Veiligheid
Debt / Equity
1,30
Boven sectorgemiddelde (0,30)
Current Ratio1,13
Interest Coverage0,43
Waardering
PE (TTM)
1961,98
Boven sectorgemiddelde (-1,49)
P/B Ratio143,45
EV/EBITDA476,50
Dividend Yield5,49%
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1962,0 | -1,5 |
| P/B | 143,5 | 1,6 |
| ROE % | 7,2 | -54,5 |
| Net Margin % | 2,3 | -41,5 |
| Rev Growth 5Y % | -21,7 | 1,8 |
| D/E | 1,3 | 0,3 |
Koersdoel Analisten
Consensus van analisten: gemiddeld koersdoel vs huidige prijs en beoordeling.
Geen analistendekking beschikbaar
Winstschattingen
Analistprognoses voor EPS en omzet per periode. Jaar = boekjaren; kwartaal = komende kwartalen.
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 | € 0,25 | 2,10 B | — |
No quarterly estimates available
Dividendgeschiedenis
Rendement
5,49%
Uitkeringsratio
18333,33%
Groei (3 jr)
0,00%
Groei (5 jr)
15,18%
Recente betalingen per aandeel (nieuwste eerst).
| Ex-dividend | Betaling | Bedrag / aandeel |
|---|---|---|
| Feb 27, 2026 | — | € 13,75 |
| Dec 01, 2025 | — | € 13,75 |
| Aug 29, 2025 | — | € 13,75 |
| May 30, 2025 | — | € 13,75 |
| Feb 28, 2025 | — | € 13,75 |
| Nov 29, 2024 | — | € 13,75 |
| Aug 30, 2024 | — | € 13,75 |
| May 31, 2024 | — | € 13,75 |
| Feb 29, 2024 | — | € 13,75 |
| Nov 30, 2023 | — | € 13,75 |
| Aug 29, 2023 | — | € 13,75 |
| May 25, 2023 | — | € 13,75 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,92% | Revenue Growth (3Y) | -16,24% |
| Earnings Growth (1Y) | -93,53% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -21,72% | Earnings Growth (5Y) | -10,59% |
| Profitability | |||
| Revenue (TTM) | 2,69 B | Net Income (TTM) | 62,00 M |
| ROE | 7,23% | ROA | 1,55% |
| Gross Margin | N/A | Operating Margin | 0,97% |
| Net Margin | 2,31% | Free Cash Flow (TTM) | -210,00 M |
| ROIC | 0,71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,30 | Current Ratio | 1,13 |
| Interest Coverage | 0,43 | Asset Turnover | 0,67 |
| Working Capital | 150,00 M | Tangible Book Value | -762,00 M |
| Dividends | |||
| Dividend Yield | 5,49% | Payout Ratio | 18333,33% |
| Dividend Growth (3Y) | 0,00% | Dividend Growth (5Y) | 15,18% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 1961,98 | Forward P/E | N/A |
| P/B Ratio | 143,45 | P/S Ratio | 45,27 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 476,50 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,17% | ||
| Market Cap | 121,64 B | Enterprise Value | 122,46 B |
| Per Share | |||
| EPS (Diluted TTM) | 0,30 | Revenue / Share | 22,13 |
| FCF / Share | -1,73 | OCF / Share | -1,73 |
| EPS CAGR (1Y) | -95,40% | EPS CAGR (5Y) | -15,19% |
| EPS CAGR (10Y) | -17,58% | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | -338,71% |
| SBC-Adj. FCF | -248,00 M | Growth Momentum | 16,80 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,69 B | 2,83 B | 3,83 B | 7,84 B | 7,16 B |
| Net Income | 62,00 M | 958,00 M | -423,00 M | 60,00 M | 97,00 M |
| EPS (Diluted) | 0,30 | 6,52 | -3,12 | 0,31 | 0,58 |
| Gross Profit | — | 149,00 M | 181,00 M | — | — |
| Operating Income | 26,00 M | -37,00 M | 37,00 M | 489,00 M | 474,00 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 155,00 M | 157,00 M | 185,00 M | 217,00 M | 268,00 M |
| SG&A Expenses | 453,00 M | 459,00 M | 740,00 M | 1,15 B | 1,15 B |
| D&A | 231,00 M | 297,00 M | 559,00 M | 610,00 M | 517,00 M |
| Interest Expense | 60,00 M | 134,00 M | 294,00 M | 285,00 M | 238,00 M |
| Income Tax | -73,00 M | 4,00 M | 204,00 M | 148,00 M | 186,00 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,92 B | 4,45 B | 4,99 B | 11,51 B | 11,64 B |
| Total Liabilities | 2,77 B | 3,25 B | 4,69 B | 9,75 B | 10,11 B |
| Shareholders' Equity | 948,00 M | 933,00 M | 25,00 M | 1,48 B | 1,26 B |
| Total Debt | 1,11 B | 1,11 B | 2,59 B | 5,82 B | 5,68 B |
| Cash & Equivalents | 231,00 M | 724,00 M | 262,00 M | 505,00 M | 447,00 M |
| Current Assets | 1,10 B | 1,67 B | 1,21 B | 3,08 B | 2,88 B |
| Current Liabilities | 1,07 B | 1,42 B | 1,33 B | 2,71 B | 2,81 B |
{"event":"ticker_viewed","properties":{"ticker":"NCRRP","listing_kind":"stock","pathname":"/stocks/ncrrp","exchange":"NYSE","country":"US"}}